Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Tilray

BrewDog US bars to be bought by firm behind UK rescue deal

Tilray Brands said it had agreed to acquire certain key assets across North America.

Evening Standard

Small investors turn on James Watt after BrewDog co-founder admits ‘many mistakes’

Watt apologises to 200,000-plus ‘equity punks’ who joined crowdfunding rounds but were left empty-handed after cut-price sale

The Guardian - UK

Brewdog News: Almost 500 Brits Set To Lose Their Jobs After American Firm Tilray Takes Over

BrewDog's acquisition by Tilray Brands leads to job losses and strategic changes. Discover the impact and future plans for the Scottish craft brewer

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Full list of BrewDog bars closing down after sale to US firm

Tilray has bought the BrewDog brand, its UK brewing operation and 11 of its pub venues across the UK and Ireland as part of the rescue deal

The Independent UK

BrewDog: List of 38 bars closing down and 11 included in rescue deal

Administrators for the brewer said 38 bars are to close ‘with immediate effect’, while 11 have been acquired in the rescue deal.

Evening Standard

Brewdog sold to US firm for £33m with 38 bars to close and 484 jobs lost

Almost 500 redundancies will be made, though more than 700 roles will be preserved

The Independent UK

BrewDog to close dozens of bars following US takeover

IN FULL

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

BrewDog to shut 38 bars with 484 job losses despite US takeover deal

Tilray Brands, which produces medicinal cannabis and craft beer in the US, bought the BrewDog brand in a £33 million deal.

Evening Standard

BrewDog bought by US cannabis and drinks firm for £33m, costing nearly 500 jobs

Many early-stage crowdfunders left empty-handed as Tilray acquires beer company’s UK and Irish assets

The Guardian - UK

The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations

Federal rescheduling efforts, coupled with improved corporate balance sheets, may finally unlock long-awaited profitability for cannabis-sector leaders.

MarketBeat

Nike, Tilray, and Palantir: Their Unusually Active Put Options Will Boost Your Wallet After Christmas

Christmas has gotten more expensive this year due to inflation and tariffs. Americans of all stripes can use a break. These six unusually active put options from Thursday trading could boost your wallet the day after Christmas. Ho. Ho. Ho!

Barchart

Option Traders Are Pricing a Nearly 22% Move in Tilray Stock Before the End of 2025. Should You Buy, Sell, or Hold TLRY Here?

Tilray stock soared today after President Donald Trump signalled reclassification of cannabis as a Schedule III drug in the near-term. Here’s what that means for TLRY shares heading into 2026.

Barchart

As Trump Considers Signing a Cannabis Executive Order, Should You Buy the Dip in Tilray Stock?

Down almost 98% from all-time highs, Tilray is a Canada-based cannabis stock that surged over 40% on Friday.

Barchart

Why Tilray Stock Is Sliding Again Wednesday

Tilray Brands Inc (NASDAQ:TLRY) shares are trading lower Wednesday morning, extending a 24% drop over the trailing five sessions following the execution of a corporate restructuring. Here’s what investors need to know.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Robinhood, Beyond Meat, Tilray Brands, ASML And SMX (Security Matters): Why These 5 Stocks Are On Investors' Radars Today

Stocks surged ahead of the Thanksgiving holiday, with the tech-heavy Nasdaq leading the charge, gaining 0.82% to 23,214.69. The SP 500 gained 0.69% to 6,812.61, while the Dow Jones Industrial Average gained 0.67% to 47,427.12.Investors are optimistic as the market enters a typically strong period for corporate sales. Fresh labor-market…

Benzinga

Tilray Shares Tumble After Company Announces 1-For-10 Reverse Stock Split

Tilray Brands Inc (NASDAQ:TLRY) shares are trading lower in Wednesday’s after-hours session after the company announced a reverse stock split.

Benzinga

Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use

Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here’s what investors need to know.

inkl

Riding the Green Wave: Exposure to the CBD market

As the cannabidiol (CBD) market continues its upward growth trajectory, investors are looking for exposure to this substance.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

What's Going On With Tilray Brands Stock Today?

Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading lower on Tuesday.

Barchart

Should You Buy, Sell, or Hold Tilray Stock After Q1 Earnings?

Tilray’s strong Q1 sent cannabis stocks flying, but sustaining this high means proving profits, not just promises.

Benzinga

Tilray Stock Is Sliding Friday: What's Going On?

Tilray Brands Inc (NASDAQ:TLRY) shares are trading lower Friday morning, a sharp reversal after the stock hit a new 52-week high on Thursday. Here’s what investors need to know.

Benzinga

Tilray (TLRY) Stock Surges To New 52-Week High On Strong Q1 Earnings Report

Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher Thursday afternoon following the release of a strong first-quarter fiscal 2026 earnings report. Here’s what investors need to know.

Benzinga

Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt

Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings.

Barchart

As Tilray Expands Its Medical Cannabis Business, Should You Buy, Sell, or Hold TLRY Stock?

Tilray’s rapid expansion in Germany and the launch of five new EU-GMP-certified craft products put it at the forefront of Europe’s largest medical cannabis market, but current analyst targets remain below the stock’s price.

MarketBeat

Is Tilray's Stock Price Surge a Pipe Dream of Political Hype?

Tilray's stock surge, fueled by political commentary and a technical squeeze, is now focusing market attention on its strong financial health.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Palantir Technologies

Robinhood Markets, Inc.

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.